Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk of atypical femoral fracture during and after bisphosphonate use.

Literature DB >> 25184886

Risk of atypical femoral fracture during and after bisphosphonate use.

Jörg Schilcher¹, Veronika Koeppen, Per Aspenberg, Karl Michaëlsson.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Diphosphonates

Year: 2014 PMID： 25184886 DOI： 10.1056/NEJMc1403799

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

43 in total

1. Atypical femur fractures: a survey of current practices in orthopedic surgery.

Authors: P S Schneider; M Wall; J P Brown; A M Cheung; E J Harvey; S N Morin
Journal: Osteoporos Int Date: 2017-08-02 Impact factor: 4.507

2. Duration of anti-resorptive therapy for osteoporosis.

Authors: Robert A Adler
Journal: Endocrine Date: 2015-10-03 Impact factor: 3.633

3. Denosumab after 8 years.

Authors: I R Reid
Journal: Osteoporos Int Date: 2015-10-16 Impact factor: 4.507

4. Avoiding open reduction and internal fixation in the intramedullary nailing of subtrochanteric femoral fractures.

Authors: S F Bellringer; C Gee; D G G Wilson; P Stott
Journal: Ann R Coll Surg Engl Date: 2015-04 Impact factor: 1.891

5. Bisphosphonate drug holidays: we reap what we sow.

Authors: S L Silverman; J D Adachi; E Dennison
Journal: Osteoporos Int Date: 2015-12-14 Impact factor: 4.507

Review 6. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors: Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal: J Bone Miner Res Date: 2016-01 Impact factor: 6.741

Risk of atypical femoral fracture during and after bisphosphonate use.

1. Atypical femur fractures: a survey of current practices in orthopedic surgery.

2. Duration of anti-resorptive therapy for osteoporosis.

3. Denosumab after 8 years.

4. Avoiding open reduction and internal fixation in the intramedullary nailing of subtrochanteric femoral fractures.

5. Bisphosphonate drug holidays: we reap what we sow.

Review 6. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

7. Atypical femur fracture during bisphosphonate drug holiday: a case series.

Review 8. Intravenous zoledronate for osteoporosis: less might be more.

9. Postmenopausal Osteoporosis.

Review 10. Optimising the management of osteoporosis.